Dimensional Fund Advisors LP grew its holdings in Select Medical Holdings Co. (NYSE:SEM) by 1.8% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 8,289,370 shares of the health services provider’s stock after acquiring an additional 146,892 shares during the period. Dimensional Fund Advisors LP owned about 6.19% of Select Medical worth $159,154,000 as of its most recent filing with the Securities & Exchange Commission.
Several other large investors have also bought and sold shares of SEM. Hood River Capital Management LLC purchased a new stake in shares of Select Medical during the 3rd quarter worth $19,840,000. Vanguard Group Inc. lifted its position in shares of Select Medical by 3.9% during the 2nd quarter. Vanguard Group Inc. now owns 9,929,821 shares of the health services provider’s stock worth $152,423,000 after purchasing an additional 369,044 shares during the last quarter. Voya Investment Management LLC lifted its position in shares of Select Medical by 24.5% during the 2nd quarter. Voya Investment Management LLC now owns 1,850,668 shares of the health services provider’s stock worth $28,407,000 after purchasing an additional 364,721 shares during the last quarter. Northern Trust Corp lifted its position in shares of Select Medical by 14.6% during the 2nd quarter. Northern Trust Corp now owns 2,325,289 shares of the health services provider’s stock worth $35,694,000 after purchasing an additional 296,087 shares during the last quarter. Finally, Sirios Capital Management L P purchased a new stake in shares of Select Medical during the 2nd quarter worth $3,180,000. Institutional investors and hedge funds own 77.93% of the company’s stock.
Shares of Select Medical Holdings Co. (NYSE SEM) traded up $0.10 on Thursday, reaching $16.85. 1,643,300 shares of the company were exchanged, compared to its average volume of 884,088. Select Medical Holdings Co. has a 52-week low of $12.00 and a 52-week high of $19.77. The stock has a market capitalization of $2,241.56, a PE ratio of 21.20, a PEG ratio of 1.31 and a beta of 1.35. The company has a current ratio of 1.51, a quick ratio of 1.51 and a debt-to-equity ratio of 3.36.
Select Medical (NYSE:SEM) last announced its quarterly earnings results on Thursday, November 2nd. The health services provider reported $0.14 earnings per share for the quarter, missing analysts’ consensus estimates of $0.16 by ($0.02). Select Medical had a net margin of 2.21% and a return on equity of 11.44%. The company had revenue of $1.10 billion during the quarter, compared to analysts’ expectations of $1.10 billion. During the same period last year, the firm earned $0.06 earnings per share. Select Medical’s revenue was up 4.1% on a year-over-year basis. analysts anticipate that Select Medical Holdings Co. will post 0.85 earnings per share for the current fiscal year.
Several equities research analysts have recently issued reports on the stock. Zacks Investment Research cut shares of Select Medical from a “hold” rating to a “sell” rating in a research report on Wednesday. Deutsche Bank reaffirmed a “buy” rating and set a $22.00 price objective on shares of Select Medical in a research report on Monday, November 6th. Robert W. Baird set a $25.00 price objective on shares of Select Medical and gave the stock a “buy” rating in a research report on Monday, October 23rd. Royal Bank of Canada reaffirmed a “buy” rating and set a $19.00 price objective on shares of Select Medical in a research report on Friday, October 13th. Finally, ValuEngine cut shares of Select Medical from a “buy” rating to a “hold” rating in a research report on Monday, October 2nd. Two research analysts have rated the stock with a sell rating, three have given a hold rating and four have issued a buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $19.50.
In related news, insider Michael E. Tarvin sold 18,500 shares of the business’s stock in a transaction on Monday, October 30th. The shares were sold at an average price of $18.97, for a total value of $350,945.00. Following the completion of the sale, the insider now directly owns 340,044 shares of the company’s stock, valued at $6,450,634.68. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, insider Scott A. Romberger sold 5,000 shares of the business’s stock in a transaction on Wednesday, November 29th. The shares were sold at an average price of $17.97, for a total transaction of $89,850.00. Following the completion of the sale, the insider now directly owns 168,211 shares of the company’s stock, valued at $3,022,751.67. The disclosure for this sale can be found here. 19.93% of the stock is owned by insiders.
TRADEMARK VIOLATION WARNING: This piece was reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this piece on another domain, it was stolen and reposted in violation of US and international copyright and trademark law. The original version of this piece can be accessed at https://www.dispatchtribunal.com/2017/12/14/dimensional-fund-advisors-lp-boosts-holdings-in-select-medical-holdings-co-sem.html.
Select Medical Profile
Select Medical Holdings Corporation is an operator of specialty hospitals, outpatient rehabilitation clinics and occupational medicine centers in the United States. The Company’s segments include specialty hospitals, outpatient rehabilitation, Concentra and Other. The specialty hospitals segment consists of hospitals designed to serve the needs of long term acute patients and hospitals designed to serve patients that require intensive medical rehabilitation care.
Want to see what other hedge funds are holding SEM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Select Medical Holdings Co. (NYSE:SEM).
Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.